Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. British Journal of Cancer

A Ruzzo1,23, F Graziano2,23, Fabio Galli3, Francesca Galli3, E Rulli3, S Lonardi4, M Ronzoni5, B Massidda6, V Zagonel4, N Pella7, C Mucciarini8, R Labianca9, M T Ionta6, I Bagaloni1, E Veltri10, P Sozzi11, S Barni12, V Ricci5, L Foltran13, M Nicolini14, E Biondi15, A Bramati16, D Turci17, S Lazzarelli18, C Verusio19, F Bergamo4, A Sobrero20, […]

Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. Plos One

Gianni Bussolati1, Laura Annaratone1, Enrico Berrino2, Umberto Miglio2, Mara Panero2, Marco Cupo1, Patrizia Gugliotta1, Tiziana Venesio2, Anna Sapino1,2, Caterina Marchiò1,3 1Department of Medical Sciences, University of Turin, Turin, Italy 2Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia (FPO), IRCCS, Candiolo, Italy 3Pathology Division, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter